Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets, USP, 30 Extended-Release Tablets USP, Distributed By Walmart Inc., Bentonville, AR 72716, Product of India, NDC 49035-273-30.
Published December 15, 2021 · Recall initiated: November 12, 2021
Summary
FDA records drug Class III recall D-0274-2022, published December 15, 2021 and initiated November 12, 2021. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 9,984 cartons; Lot: Lot #: AC2103329B. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications
What to do
Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- USA Nationwide.
- Lot
- Lot #: AC2103329B
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVarenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJDecember 17, 2025
- FDASuccinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, ForOctober 15, 2025
- FDAOmeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy'sJuly 23, 2025
- FDALevetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, ManufacturedApril 23, 2025
- FDAAllergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets, 30December 15, 2021
- FDAFexofenadine HCl, 60 mg & Pseudoephedrine HCl 120 mg, Extended Release Tablets USP, Allergy and Congestion, 30December 15, 2021
Questions about this recall
Was Allergy Relief D Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg, Extended Release Tablets, USP, 30 Extended-Release Tablets USP, Distributed By Walmart Inc., Bentonville, AR 72716, Product of India, NDC 49035-273-30. recalled?
Yes. FDA published recall D-0274-2022 on December 15, 2021. Reported hazard: Failed dissolution specifications
What should I do if I have this product?
Letter